2m 2m 2m 2m 2m 2m 2m
MINERVA NEUROSCI (NERV)
NASDAQ
$2.40+$0.010 (+0.42%)
Price as of Oct 22, 2026 7:30 PM EDT- $114.1MMarket Cap
- -55.58%1-Year Change
- BiotechnologyIndustry
MINERVA NEUROSCI (NERV)
$2.40+$0.010 (+0.42%)
NERV | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $2.39 | ||
Change | -$0.14 (-5.53%) | ||
Open | $2.53 | ||
High | $2.59 | ||
Low | $2.39 | ||
Previous Close | $2.53 | ||
Volume | 102,618 | ||
30-Day Average Volume | 120,873 | ||
1-Week Change | 1.70% | ||
1-Month Change | -35.14% | ||
1-Year Change | -55.58% | ||
3-Year Change | -56.47% | ||
5-Year Change | -77.02% | ||
Fundamentals | |||
Shares Outstanding | 47.7M | ||
Total Assets | $95.1M | ||
Market Cap | $114.1M | ||
Enterprise Value | $89.5M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | $17.5M | ||
Free Cash Flow | -$13.3M | ||
EBIT | $17.5M | ||
EBITDA | $17.5M | ||
Net Working Capital | $75.8M | ||
EPS | -$0.14 | ||
Enterprise Value/EBITDA | 5 | ||
Enterprise Value/Revenue | N/A | ||
P/B | -1 | ||
P/E | -17 | ||
PEG | -0 | ||
Price/Free Cash Flow | -9 | ||
Price/Operating Cash Flow | -9 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 8 | ||
Last Split Date | 06/21/2022 | ||
Earnings & Revenue